1 Min Read
June 2 (Reuters) - Pfizer Inc:
* “For Pfizer’s US Biopharma business as of the first quarter, the weighted average net selling price increase YTD is 4% in the US” Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.